Loti 21 Insulin Human (25/75)
| Contracted Institution | Ministry of Health | ||||||||||
| Tenderer Institution | Ministry of Health | ||||||||||
| Tender object | B7- Blerje barna Antineoplastike, immunomodulatore, metabolizmi dhe trakti tretes - Loti 21 Insulin Human (25/75) | ||||||||||
| Reference No. | REF-08515-02-16-2019 | ||||||||||
| Estimated / Ceiling Value ALL without VAT | 376 966,00 | ||||||||||
| Type of Contract | |||||||||||
| Procurement Method | Open Procedure | ||||||||||
| Stage Procedure | Announced the Winner | ||||||||||
| Tender Publication Date | 18-02-2019 | ||||||||||
| Last date of Submitted Documents | 13-03-2019 | ||||||||||
| Tender Held Date | 13-03-2019 | ||||||||||
| No. of Bidders | 3 | ||||||||||
| Bidders |
Imi Farma Evita Fufarma |
||||||||||
| Successful Bidder /Supplier / Provider |
|
||||||||||
| The winning bid ALL without vat | 492 leke per njesi pa TVSH | ||||||||||
| Bidder Announcement date | |||||||||||
| Award and Contract Amount ALL with VAT | |||||||||||
| Contract date | |||||||||||
| Planned Milestones of Contract / Start and End Date | 12 muaj | ||||||||||
| Renewal Contract Additional Value (ALL with VAT) |
|
||||||||||
| Appeals | Nuk ka pasur ankesa dhe skualifikime. | ||||||||||
| Cancellation reason | |||||||||||
| Additions | |||||||||||
| Transaction / Actual Spending |
|
||||||||||
| Public Announcement Bulletin |
|